Skip Navigation



Annals of Oncology Advance Access published online on April 29, 2008
Annals of Oncology, doi:10.1093/annonc/mdn177
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/6/1208    most recent
mdn177v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Schoor, G.
Right arrow Articles by Verbeek, A. L. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Schoor, G.
Right arrow Articles by Verbeek, A. L. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letter to the editor

A rationale for starting breast cancer screening under age 50

The first 10% of the full text of this article appears below.

Most countries which have implemented service screening on breast cancer invite women from age 50 [1]. With regard to younger women, findings from the UK age trial [2] showed the same trend as previous studies [3] that screening below age 50 has a positive effect on breast cancer mortality. For women screened at 40–49, Moss et al. [2] reported a breast cancer mortality reduction of 17% at . . . [Full Text of this Article]

G. van Schoor1,*, M. J. M. Broeders1,2, E. Paap1, J. D. M. Otten1, G. J. den Heeten2 and A. L. M. Verbeek1

1 Department of Epidemiology, Biostatistics and Health Technology Assessment
2 National Expert and Training Centre for Breast Cancer Screening, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

* (E-mail: g.vanschoor@epib.umcn.nl)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?